The Joint Corp Q2 revenue rises 24% to $25.1M, net income plunges to $345k from $2.7M

JOINT Corp

2022-Q2 EPS reported $0.01 revenue$47,495,856

Revenue $25.1M (+24% YoY); net income $345k ($0.02 EPS) vs $2.7M ($0.18) prior year.
Adjusted EBITDA $2.6M, down from $3.8M; operating income $473k vs $2.0M.
System-wide sales $106M (+21%); system-wide comp sales +8%; total clinics 769 (+33 net).
Cash $9.4M at June 30, down from $19.5M at Dec 31 due to clinic acquisitions and greenfields.
FY 2022 guidance reaffirmed: revenue $98-102M, Adj EBITDA $12-14M, franchised openings 110-130.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.